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MaOBJECTIVES The aim of this study was to investigate the clinical signiﬁcance of native T1 values in remote myocardium
in survivors of acute ST-segment elevation myocardial infarction (STEMI).
BACKGROUND The pathophysiology and prognostic signiﬁcance of remote myocardium in the natural history of
STEMI is uncertain. Cardiac magnetic resonance (CMR) reveals myocardial function and pathology. Native T1 (relaxation
time in ms) is a fundamental magnetic resonance tissue property determined by water content and cellularity.
RESULTS A total of 300 STEMI patients (mean age 59 years; 74% male) gave informed consent. A total of 288 STEMI
patients had evaluable native T1 CMR, and 267 patients (91%) had follow-up CMR at 6 months. Health outcome
information was obtained for all of the participants (median follow-up 845 days). Infarct size was 18  13% of left
ventricular (LV) mass. Two days post-STEMI, native T1 was lower in remote myocardium than in the infarct zone (961 
25 ms vs. 1,097  52 ms; p < 0.01). In multivariable regression, incomplete ST-segment resolution was associated with
myocardial remote zone native T1 (regression coefﬁcient 9.42; 95% conﬁdence interval [CI]: 2.37 to 16.47; p ¼ 0.009),
as were the log of the admission C-reactive protein concentration (3.01; 95% CI: 0.016 to 5.85; p ¼ 0.038) and the peak
monocyte count (10.20; 95% CI: 0.74 to 19.67; p ¼ 0.035). Remote T1 at baseline was associated with log N-terminal
pro–B-type natriuretic peptide at 6 months (0.01; 95% CI: 0.00 to 0.02; p ¼ 0.002; n ¼ 151) and the change in LV end-
diastolic volume from baseline to 6 months (0.13; 95% CI: 0.01 to 0.24; p ¼ 0.035). Remote zone native T1 was
independently associated with post-discharge major adverse cardiac events (n ¼ 20 events; hazard ratio: 1.016; 95% CI:
1.000 to 1.032; p ¼ 0.048) and all-cause death or heart failure hospitalization (n ¼ 30 events during admission and
post-discharge; hazard ratio: 1.014; 95% CI: 1.000 to 1.028; p ¼ 0.049).
CONCLUSIONS Reperfusion injury and inﬂammation early post-MI was associated with remote zone T1, which in turn
was independently associated with LV remodeling and adverse cardiac events post-STEMI. (Detection and Signiﬁcance of
Heart Injury in ST Elevation Myocardial Infarction [BHF MR-MI]; NCT02072850) (J Am Coll Cardiol Img 2015;8:779–89)
© 2015 The Authors. Published by Elsevier. This is an open access article under the CC BY license
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ABBR EV I A T I ON S
AND ACRONYMS
CMR = cardiac magnetic
resonance
CRP = C-reactive protein
ECG = electrocardiogram
LV = left ventricular
MACE = major adverse
cardiac events
NT-proBNP = N-terminal pro–
B-type natriuretic peptide
PCI = percutaneous coronary
intervention
STEMI = ST-segment elevation
myocardial infarction
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780T he pathophysiology of left ventricu-lar (LV) dysfunction and remodelingafter acute ST-segment elevation
myocardial infarction (STEMI) is incom-
pletely understood (1–4). Acute MI triggers a
systemic acute-phase response, and neutro-
phils and monocytes/macrophages track to
infarct (5–7) and remote (8,9) myocardial tis-
sues from reticuloendothelial stores (5–7).
Proof-of-concept studies in humans support
the experimental observations (8,10). Local
cytokine production from cardiomyocytes
and macrophages represents an acute stress
response to injury within the ﬁrst week
post-MI (9,11), leading to maladaptive matrixmodiﬁcations that are associated with impaired
contractility in the myocardial remote zone (7). Sys-
temic inﬂammation is prognostically important post-
MI (12), and evidence-based therapies for MI may
reduce inﬂammatory activation (13).SEE PAGE 790Human tissue has fundamental magnetic proper-
ties, including the longitudinal (spin-lattice) proton
relaxation time (native T1 in ms). Native T1 is inﬂuen-
ced by water content, binding with macromolecules,E 1 Two Patients With Anterior STEMI and Divergent Clinical
atients had similar clinical presentations, with acute anterior ST-seg
s coronary intervention. The yellowarrow indicates the location of th
al, branch of the left coronary artery. The history of each patient isand cell composition (14,15). Tissue water content
increases as a result of ischemia, resulting in
longer T1 times being a biomarker of more severe
myocardial injury in localized myocardial regions
(15–17). Cardiac magnetic resonance (CMR) now en-
ables spatially resolved measurement of native T1
(T1 mapping) in the heart without using a gadolin-
ium contrast agent that is normally required to
delineate infarct tissue. However, the potential of
native T1 to be used as a novel biomarker of heart
injury in STEMI patients is not completely under-
stood (7,18–24) (Figure 1).
We hypothesized that regional myocardial tissue
characteristics reﬂected by native T1 would be asso-
ciated with the initial extent of ischemic injury and
systemic inﬂammation. Our second hypothesis was
that remote myocardial characteristics (native T1)
would be independently associated with LV remod-
eling and pre-deﬁned cardiovascular outcomes and
mortality in the longer term.
METHODS
STUDY POPULATION AND STEMI MANAGEMENT. We
performed a prospective CMR cohort study in a single
regional cardiac center between May 11, 2011, andCourses
ment elevation myocardial infarction (STEMI) treated by primary percu-
e thrombotic occlusion of the (A) left anterior descending, and (B) obtuse
described in the Online Appendix. MRI ¼ magnetic resonance imaging.
FIGURE 2 Flow Diagram of the Cohort Study
CMR ¼ cardiac magnetic resonance; other abbreviation as in Figure 1.
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781November 22, 2012. A total of 343 STEMI patients
provided written informed consent. The eligibility
criteria included an indication for primary percuta-
neous coronary intervention (PCI) or thrombolysis
for STEMI (25). Exclusion criteria represented stan-
dard contraindications to contrast CMR. Acute
STEMI management followed contemporary guide-
lines (25,26). The study had ethics approval (refer-
ence 10-S0703-28) and was publically registered. Fifty
healthy volunteers also underwent CMR (Online
Appendix).
CMR ACQUISITION. CMR was performed on a
MAGNETOM Avanto (Siemens Healthcare, Erlangen,
Germany) 1.5-T scanner with a 12-element phased-
array cardiac surface coil 2 days and 6 months post-
MI (27,28). The imaging protocol (Online Appendix)
included cine CMR with steady-state free preces-
sion, native T1 relaxometry (mapping) using an opti-
mized modiﬁed look-locker inversion-recovery
investigational prototype sequence (work-in-progress
448, Siemens Healthcare) (21,22,29), T2 mapping
(30,31), and delayed-enhancement phase-sensitive
inversion-recovery pulse sequences (32). Patients
and healthy volunteers underwent the same imag-
ing protocol, with the exception that healthy
volunteers<45 years of age did not receive gadolinium
(Online Appendix).
CMR ANALYSES. The CMR analyses are described in
the Online Appendix.
T1-standardized measurements in myocardial regions of
interest. LV contours were delineated with computer-
assisted planimetry on the raw T1 image and copied
onto the color-encoded spatially coregistered maps.
Apical segments were not included because of partial
volume effects. Particular care was taken to delineate
regions of interest with adequate margins of separa-
tion from tissue interfaces prone to partial volume
averaging, such as between myocardium and blood
(27,28,33). The presence of off-resonance artifacts
and cardiorespiratory motion was assessed by exam-
ination of the raw T1-weighted images. A total of 300
segments (8.6%) were excluded from analysis due
to the presence of off-resonance or motion artifacts.
In STEMI patients, myocardial T1 values were
segmented spatially and regions of interest were
deﬁned as: 1) remote myocardium; 2) injured myo-
cardium; or 3) infarct core. The regions of interest
were planimetered to include the entire area of in-
terest with distinct margins of separation from tissue
interfaces to exclude partial volume averaging. The
remote myocardial region of interest was deﬁned as
myocardium 180 from the affected zone with no
visible evidence of infarction, edema, or wall motionabnormalities (assessed by inspecting corresponding
contrast-enhanced T1-weighted, T2-weighted, or cine
images, respectively). The infarct zone region of
interest was deﬁned as myocardium with pixel
values (T1 or T2) >2 SD from remote myocardium on
T2-weighted CMR (29–31). The infarct core was
deﬁned as an area in the center of the infarct territory
having a mean T1 value of at least 2 SD below the T1
value of the periphery of the area at risk.
Infarct deﬁnition and size. The myocardial mass of
late gadolinium (g) was quantiﬁed using computer-
assisted planimetry, and the territory of infarction
was delineated using a signal intensity threshold of
>5 SD above a remote reference region and expressed
as a percentage of total LV mass (33).
Area at risk. Area at risk was deﬁned as LV myocar-
dium with pixel values (T1/T2) >2 SD from remote
myocardium (4,23,24,34–36).
Myocardial salvage. Myocardial salvage was calculated
by subtraction of percentage infarct size from per-
centage area at risk (4,34–36). The myocardial salvage
index was calculated by dividing the myocardial
salvage area by the initial area at risk.
TABLE 1 Clinical and Angiographic Characteristics of 288 Patients With STEMI Who Had CMR With Evaluable Myocardial Native T1 Maps
All Patients (N ¼ 288)
STEMI Patient Group in Tertiles, Remote Zone Native T1 at Baseline
p Value*#951 ms (n ¼ 96) >951 to #969 ms (n ¼ 96) >969 ms (n ¼ 96)
Age, yrs 59  12 59  11 58  12 60  11 0.727
Male 211 (73) 78 (81) 73 (76) 60 (62) 0.011
BMI, kg/m2 29  5 29  4 29  5 29  5 0.910
Hypertension 93 (32) 26 (27) 33 (34) 34 (35) 0.418
Current smoking 177 (62) 55 (57) 61 (64) 61 (64) 0.640
Hypercholesterolemia 82 (28) 24 (25) 26 (27) 32 (33) 0.415
Diabetes mellitus† 32 (11) 12 (12) 13 (14) 7 (7) 0.354
Previous angina 34 (12) 11 (12) 10 (10) 13 (14) 0.850
Previous myocardial infarction 23 (8) 4 (4) 7 (7) 12 (12) 0.119
Previous PCI 16 (6) 4 (4) 6 (6) 6 (6) 0.852
Presenting characteristics
Heart rate, beats/min 78  17 77  16 77  17 80  16 0.526
Systolic blood pressure, mm Hg 136  24 134  25 139  25 134  23 0.286
Diastolic blood pressure, mm Hg 79  14 78  12 82  14 76  15 0.062
Time from symptom onset to
reperfusion, min
254  217 254  213 227  212 283  225 0.226
Ventricular ﬁbrillation‡ 20 (7) 7 (7) 7 (7) 7 (6) 1.000
Heart failure Killip class§
I 205 (71) 73 (76) 73 (76) 59 (62)
II 64 (22) 19 (20) 17 (17) 29 (30) 0.142
III or IV 19 (7) 4 (4) 7 (7) 8 (8)
ECG
ST-segment elevation
resolution post-PCI
Complete, $70% 129 (45) 54 (56) 42 (44) 33 (34)
Incomplete, 30% to <70% 115 (40) 29 (30) 41 (43) 45 (47) 0.036
None, #30% 43 (15) 13 (14) 12 (13) 18 (19)
Coronary angiography
Reperfusion strategy
Primary PCI 268 (93) 86 (90) 90 (94) 92 (96)
Rescue PCI (failed thrombolysis) 13 (4) 6 (6) 4 (4) 3 (3) 0.527
Successful thrombolysis 7 (2) 4 (4) 2 (2) 1 (1)
Number of diseased arteriesk
1 156 (54) 53 (55) 57 (59) 46 (48)
2 84 (29) 30 (31) 26 (27) 28 (29) 0.388
3 42 (15) 10 (10) 12 (12) 20 (21)
Left main 6 (2) 3 (3) 1 (1) 2 (2)
Culprit artery
Left anterior descending 108 (38) 32 (33) 35 (36) 41 (43)
Left circumﬂex 51 (18) 11 (12) 22 (23) 18 (19) 0.081
Right coronary 129 (45) 53 (55) 39 (41) 37 (38)
TIMI coronary ﬂow grade pre-PCI
0/1 208 (72) 62 (65) 73 (76) 73 (76)
2 52 (18) 20 (21) 14 (15) 18 (19) 0.158
3 28 (10) 14 (15) 9 (9) 5 (5)
TIMI coronary ﬂow grade post-PCI
0/1 3 (1) 1 (1) 1 (1) 1 (1)
2 13 (4) 4 (4) 5 (5) 4 (4) 1.000
3 272 (94) 91 (95) 90 (94) 91 (95)
Continued on the next page
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as an increase in LV end-diastolic volume $20% at
6 months from baseline (3).
LABORATORY ANALYSES. The acquisition of the
electrocardiograms (ECGs) and blood samples forbiochemical and hematologic analyses are described
in the Online Appendix.
PRE-SPECIFIED HEALTH OUTCOMES. We pre-
speciﬁed adverse health outcomes that are patho-
physiologically linked with STEMI. The primary
TABLE 1 Continued
All Patients (N ¼ 288)
STEMI Patient Group in Tertiles, Remote Zone Native T1 at Baseline
p Value*#951 ms (n ¼ 96) >951 to #969 ms (n ¼ 96) >969 ms (n ¼ 96)
Initial blood results on admission¶
C-reactive protein, mg/l
Range
3.0 (2.0–7.0)
0.0–265.0
3.0 (2.0–5.0)
0.0–43.0
4.0 (2.0–7.0)
1.0–125.0
5.0 (3.0–10.8)
1.0–265.0
0.034
Leukocyte cell count,  109/l 12.4 (3.5) 11.5 (2.9) 13.2 (3.7) 12.4 (3.6) 0.002
Neutrophil count,  109/l 9.6 (3.2) 8.7 (2.8) 10.3 (3.4) 9.7 (3.3) 0.002
Monocytes,  109/l 0.8 (0.3) 0.9 (0.4) 0.8 (0.4) 0.9 (0.4) 0.382
Values are mean  SD, n (%), median (IQR), or range. The patients are grouped according to tertiles of remote zone native T1 (ms) at baseline. p values were obtained from
1-way analysis of variance, Kruskal-Wallis test, or Fisher test. *The p value is for the association between clinical characteristic and tertiles of remote zone native T1 at
baseline. †Diabetes mellitus was deﬁned as a history of diet-controlled or treated diabetes. ‡Successfully electrically cardioverted ventricular ﬁbrillation at presentation or
during emergency PCI procedure. §Killip classiﬁcation of heart failure after acute myocardial infarction: class I ¼ no heart failure; class II ¼ pulmonary rales or crepitations, a
third heart sound, and elevated jugular venous pressure; class III ¼ acute pulmonary edema; and class IV ¼ cardiogenic shock. kMultivessel coronary artery disease was
deﬁned according to the number of stenoses of at least 50% of the reference vessel diameter by visual assessment and whether or not there was left main stem
involvement. ¶The blood results on admission and their changes during the ﬁrst 2 days after admission are described in Online Table 1. C-reactive protein levels were
available for 281 participants.
BMI ¼ body mass index; CMR ¼ cardiac magnetic resonance; ECG ¼ electrocardiogram; IQR ¼ interquartile range; PCI ¼ percutaneous coronary intervention; STEMI ¼
ST-segment elevation myocardial infarction; TIMI ¼ Thrombolysis In Myocardial Infarction.
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783composite outcome was major adverse cardiac
events (MACE), deﬁned as cardiac death, nonfatal
MI, or hospitalization for heart failure (Online
Appendix). All-cause death or heart failure hospi-
talization was a secondary outcome. The serious
adverse events were independently assessed by a
cardiologist who was not a member of the research
team. The serious adverse events were deﬁned ac-
cording to standard guidelines (Online Appendix)
and categorized as having occurred either during
the index admission or post-discharge. All study
participants were followed up by patient contacts
through telephone calls, clinic visits, and review of
the electronic medical records for a minimum of
18 months after discharge.
STATISTICAL ANALYSES. The sample size calcula-
tion and statistical methods are described in the
Online Appendix. Myocardial native T1 values in
spatially matched regions of the heart (37) in STEMI
patients and healthy volunteers were compared
using independent 2-sample Student t tests. Uni-
variable and multivariable linear regression analyses
were performed to identify associations of T1 values
for: 1) remote myocardium; 2) injured myocardium;
and 3) infarct core in all patients and in patients
without late microvascular obstruction (3). Binary
logistic regression models were used to identify
associates of adverse remodeling at the 6-month
follow-up. In stepwise linear regressions, the Akaike
information criterion (AIC) was used as a measure
of the relative quality of the models for this
dataset, and the model with the minimum AIC value
was reported. Kaplan-Meier and Cox proportionalhazards methods were used to identify potential
clinical correlates of MACE and all-cause death/heart
failure events, including patient characteristics, CMR
ﬁndings, and native T1. A p value >0.05 indicated
the absence of a statistically signiﬁcant effect.
The natural log has been used in any logarithmic
transforms of variables.
RESULTS
Of 343 STEMI patients referred for emergency PCI,
300 underwent serial CMR 2.2  1.9 days and
6 months after hospital admission (Figure 2). A total
of 292 STEMI patients had a CMR assessment of
native T1 and 288 (99%) had evaluable T1 data
(Figures 1 and 2). Each of these patients (n ¼ 288)
had vital status assessed at least 18 months after
enrollment, and CMR follow-up at 6 months was
achieved in 267 (91%) patients. The ﬂow diagram for
the study, including the reasons for nonattendance,
is shown in Figure 2.
PATIENT CHARACTERISTICS. The characteristics of
the patients with evaluable native T1 CMR data
(n ¼ 288) are shown in Table 1. The characteristics of
those patients with missing follow-up information
are described in Online Table 1. The mean age was
59  12 years, and 74% were male. Remote zone
native T1 was inversely associated with male sex.
A total of 158 patients (55%) had incomplete or no
resolution of ST-segment elevation immediately
following PCI. Circulating C-reactive protein (CRP)
levels and leukocyte counts and their changes dur-
ing serial testing in the ﬁrst 2 days post-MI are de-
scribed in Table 1 and Online Table 2, respectively.
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blockers were prescribed during the initial hospital-
ization in 285 (99%) and 278 (96.5%) of patients,
respectively.
CMR FINDINGS. Initial CMR ﬁndings during the index
hospitalization. Remote zone native T1 for patients
grouped by tertiles was associated with male sex
(p ¼ 0.011), ST-segment resolution (p ¼ 0.036),
CRP level (p ¼ 0.034), leukocyte count (p ¼
0.002), and neutrophil count (p ¼ 0.002) (Table 1).
Remote zone native T1 was not associated withTABLE 2 Comparison of CMR Findings at Baseline (n ¼ 288) and at 6
to Tertiles of Remote Zone Native T1 Values (ms) at Baseline
All Patients
STEMI P
#951 ms
CMR ﬁndings 2 days post-MI (n ¼ 288)
LV ejection fraction, % 55  10 56 
LV end-diastolic volume, ml
Men 162  33 158
Women 124  25 117
LV end-systolic volume, ml
Men 76  26 70 
Women 55  18 52 
LV mass, g
Men 144  30 140
Women 99  24 93 
Edema and infarct characteristics
Area at risk, % of LV mass 32  12 29
Infarct size, % of LV mass 18  13 16 
Myocardial salvage, % of LV mass 19  9 18
Myocardial salvage index, % of LV mass 63  24 68 
Late microvascular obstruction present 145 (50) 41
Late microvascular obstruction, % of LV mass 2.7  4.6 1.6 
Myocardial native T1 values
T1 remote myocardium (all participants), ms 961  25 935
Men, ms 959  25 935
Women, ms 968  25 938
T1 infarct zone, ms 1,097  52 1,077
T1 hypointense core present 160 (56) 50
T1 hypointense infarct core, ms 997  57 986
CMR ﬁndings 6 months post-MI (n ¼ 267)
LV ejection fraction at 6 months, % 62  9 64
LV end-diastolic volume at 6 months, ml
Men 168  37 160
Women 128  29 125
LV end-systolic volume at 6 months, ml
Men 66  30 58
Women 46  17 46 
Values are mean  SD or n (%). Area at risk was measured with T2 mapping. p values were
maps (basal-, mid-, and distal-ventricular levels) were measured in each patient (n ¼ 8
patients (6.8%) had poor-quality T1 maps and 4 patients (1.3%) had no evaluable T1 ma
free precession off-resonance artifacts, and 19 of these T1 maps were also affected by mo
(p < 0.001) and in infarct core (p < 0.001).
LV ¼ left ventricular; MI ¼ myocardial infarction; other abbreviations as in Table 1.the number of coronary arteries affected by a
stenosis of $50% severity or the culprit artery
type.
The CMR ﬁndings are summarized in Table 2, and
case examples are shown in Figure 1. At baseline, the
mean myocardial infarct size was 18  13% of LV
mass, and 51% of patients had late microvascular
obstruction. Native T1 in the remote myocardium was
lower than native T1 in the infarct zone (961  25 ms
vs. 1,097  52 ms; p < 0.01), reﬂecting infarct zone
edema.Months (n ¼ 267) in Patients With STEMI Grouped According
atient Group in Tertiles, Remote Zone Native T1 at Baseline
p Value(n ¼ 96) >951 to #969 ms (n ¼ 96) >969 ms (n ¼ 96)
10 56  9 53  10 0.041
 29 158  35 172  34 0.017
 25 131  25 124  25 0.233
23 72  26 87  27 <0.001
19 59  17 53  17 0.476
 28 142  28 152  33 0.054
25 108  25 96  22 0.064
 12 32  12 35  11 0.045
13 17  13 20  14 0.044
 9 20  9 18  8 0.370
26 64  23 57  23 0.013
(43) 51 (53) 53 (55) 0.192
3.3 3.5  5.4 3.2  4.8 0.021
 12 960  6 988  17 <0.001
 12 960  6 988  17 <0.001
 11 961  6 989  18 <0.001
 44 1,100  52 1,115  52 <0.001
(52) 52 (54) 58 (60) 0.483
 51 1,001  64 1,003  56 0.269
 8 63  8 60  11 0.010
 32 163  32 182  43 0.007
 20 128  30 128  33 0.995
 21 63  24 82  39 <0.001
16 48  19 45  18 0.895
obtained from 1-way analysis of variance, Kruskal-Wallis test, or Fisher test. Three T1
76 T1-maps overall), and 93% of these maps were suitable for analysis. Overall, 20
ps (Figure 1). Forty-two T1 maps were unsuitable for analysis because of steady-state
tion artifacts. Remote zone native T1 values were higher than T1 values in infarct tissue
TABLE 3 Association of Patient Characteristics With Native T1 (ms) in Remote
Myocardium in Univariable and Multivariable Stepwise Regression Analyses (n ¼ 288)
Multiple Stepwise Regression Coefﬁcient (95% CI) p Value
Including patient characteristics and angiographic data
Male 9.93 (16.23 to 3.62) 0.002
Previous MI 11.38 (1.10 to 21.67) 0.030
Killip class IV 28.64 (1.00 to 56.28) 0.042
No ST-segment resolution 12.05 (3.67 to 20.43) 0.005
Incomplete ST-segment resolution 9.30 (3.20 to 15.39) 0.003
Including patient characteristics, angiographic data, and CRP
Male 9.54 (16.62 to 2.47) 0.008
No ST-segment resolution 10.54 (1.11 to 19.97) 0.029
Incomplete ST-segment resolution 9.46 (2.41 to 16.50) 0.009
Log initial CRP 2.75 (0.09 to 5.58) 0.057
Including patient characteristics, angiographic data, initial CRP, and LV end-diastolic volume
Male 12.74 (20.69 to 4.79) 0.002
BMI, kg/m2 0.63 (1.33 to 0.08) 0.083
No ST-segment resolution 10.12 (0.69 to 19.56) 0.036
Incomplete ST-segment resolution 9.42 (2.37 to 16.47) 0.009
Log initial CRP 3.01 (0.016 to 5.85) 0.038
LV end-diastolic volume 0.10 (0.01 to 0.21) 0.084
Including patient characteristics, angiographic data, peak monocyte count, and LV
end-diastolic volume
Male 14.31 (22.33 to 6.29) <0.001
Previous myocardial infarction 0.63 (1.33 to 0.08) 0.083
No ST-segment resolution 10.09 (0.72 to 19.47) 0.035
Incomplete ST-segment resolution 9.23 (2.29 to 16.17) 0.009
Peak monocyte count,  109/l 10.20 (0.74 to 19.67) 0.035
LV end-diastolic volume 0.10 (0.01 to 0.21) 0.088
The coefﬁcient (95% CI) indicates the magnitude and direction of the difference in remote zone T1 (ms) for the
patient characteristic (binary or continuous). For example, on average, remote zone native T1 (ms) 2 days post-MI
was9.93 (95% CI:16.23 to3.62) lower for male versus female, and native T1 (ms) was 0.14 (95% CI: 0.01 to
0.26) higher for each 1-ml increase in LV end-systolic volume. Previous MI affecting a territory of remote
myocardium could alter native T1, which could be a confounding factor in the multivariable analysis of associates
of remote zone native T1. In a sensitivity analysis involving backward stepwise variable selection, removing
previous MI had no effect on the results of the multivariable models.
CI ¼ conﬁdence interval; CRP ¼ C-reactive protein; other abbreviations as in Tables 1 and 2.
TABLE 4 Multivariable Association of Patient Characteristics and Angiographic and
CMR Findings With LV End-Diastolic Volume at 6 Months Post-STEMI (n ¼ 267)*
Coefﬁcient (95% CI) p Value
Remote zone native T1, ms 0.16 (0.05 to 0.27) 0.005
LV end-diastolic volume at baseline, ml 0.69 (0.59 to 0.79) <0.001
Infarct size, % LV mass 0.83 (0.56 to 1.11) <0.001
Male 17.82 (10.78 to 24.86) <0.001
BMI, kg/m2 0.67 (0.02 to 1.33) 0.045
Hypercholesterolemia 6.85 (13.65 to 0.05) 0.048
Sustained ventricular arrhythmia 12.36 (1.33 to 23.39) 0.028
Reperfusion mode: successful thrombolysis 48.91 (5.71 to 92.10) 0.027
The coefﬁcient and 95% CI indicate the magnitude and direction of the difference in LV end-diastolic
volume (ml) at follow-up for the patient characteristic (binary or continuous). For example, on average,
LV end-diastolic volume (ml) at follow-up was 0.16 (95% CI: 0.05 to 0.27) higher for each 1-ms increase in
remote zone native T1 measured by CMR at baseline. The univariable associations with LV end-diastolic
volume at 6 months are described in the Online Appendix. *When area at risk was included instead of
infarct size, remote zone T1 was also associated with LV end-diastolic volume at follow-up (0.25; 95% CI: 0.09
to 0.41; p ¼ 0.002).
Abbreviations as in Tables 1 to 3.
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785CMR ﬁndings at 6 months. The CMR ﬁndings at
6 months are described in Table 2.
Myocardial native T1 in STEMI patients and healthy
volunteers. Fifty healthy volunteers (52% male; mean
age 54  13 years) also underwent CMR. At the
midventricular level, mean remote zone native T1
was similar in STEMI patients (961  25 ms) and
healthy volunteers (958  24; p ¼ 0.314) (Online
Appendix). When described in tertiles (#951, >951
to #969, and >969 ms), the upper tertile of remote
zone native T1 had values that overlapped with
T1 values observed in the infarct zone (Table 2).
The results of intraobserver and interobserver
agreement of T1 measurements are shown in Online
Figure 1.
LV OUTCOMES AT 6 MONTHS POST-MI. At 6 months,
LV end-diastolic volume increased on average by
5  25 ml (Table 2). Adverse remodeling, deﬁned as an
increase in LV end-diastolic volume by $20%,
occurred in 30 patients (12%).
BASELINE ASSOCIATES OF MYOCARDIAL REMOTE
ZONE NATIVE T1. The univariable and multivariable
baseline associates of remote zone native T1 are
described in Online Table 3 and Table 3, respectively.
In stepwise linear regression using AIC, incomplete
ST-segment resolution (regression coefﬁcient 9.42;
95% conﬁdence interval [CI]: 2.37 to 16.47; p ¼ 0.009)
and a 1-U increase in log of the initial CRP concen-
tration (3.01; 95% CI: 0.016 to 5.55; p ¼ 0.038) were
independently associated with T1. Myocardial remote
zone native T1 was approximately 10 ms higher on
average in patients with ECG evidence of reperfusion
injury. Native T1 in the remote zone increased by
approximately 10 ms, on average, for every 1  109/l
increase in peak monocyte count within 2 days of
admission (10.20; 95% CI: 0.74 to 19.67; p ¼ 0.035).
MYOCARDIAL TISSUE CHARACTERISTICS AS A MARKER
OF SUBSEQUENT LV REMODELING. Myocardial remote
zone native T1 measured 2 days post-MI was multi-
variably associated with LV end-diastolic volume at
6 months (Table 4), including in patients without
microvascular obstruction (n ¼ 121) (Online Table 4).
Remote T1 was also multivariably associated with
change in LV end-diastolic volume from baseline
(n ¼ 267) (Online Figure 2, Online Table 5) after
adjustment for initial LV end-diastolic volume,
infarct size, and microvascular obstruction.
REMOTE ZONE NATIVE T1 EARLY POST-MI AND
N-TERMINAL PRO–B-TYPE NATRIURETIC PEPTIDE,
A BIOCHEMICAL MEASURE OF LV REMODELING,
AT 6 MONTHS. Blood samples had been collected
in STEMI patients enrolled during ofﬁce hours,
and N-terminal pro–B-type natriuretic peptide
FIGURE 3 Remote Zone Native T1 and NT-proBNP 6 Months Post-MI
Remote zone native T1 (ms) at baseline was associated with N-terminal pro–B-type
natriuretic peptide (NT-proBNP) (median [interquartile range]) after 6 months (n ¼ 151
patients with ST-segment elevation myocardial infarction) (Online Appendix).
MI ¼ myocardial infarction.
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786(NT-proBNP) results were available in 151 patients.
The clinical and CMR characteristics of these patients
were similar to those of the whole cohort (Online
Tables 6 and 7).
Remote zone native T1 and NT-proBNP levels
were not associated at baseline. By contrast, the
concentrations of NT-proBNP at 6 months differed
between the lowest versus highest tertiles of remote
zone native T1 at baseline (Figure 3). This relation-
ship remained after adjustment for LV ejection
fraction and volumes. Speciﬁcally, remote zone
native T1 at baseline in tertiles (lowest tertile ¼
reference; intermediate tertile p ¼ 0.145; upper ter-
tile p ¼ 0.013) was associated with log NT-proBNP at
6 months after adjustment for NT-proBNP at baseline
(0.01 on log scale; 95% CI: 0.00 to 0.02; p ¼ 0.049),
independently of LV ejection fraction (p ¼ 0.064)
and LV end-diastolic volume at baseline (p ¼ 0.046)
(Figure 3).
MYOCARDIAL REMOTE ZONE T1 AND HEALTH
OUTCOMES IN THE LONGER TERM. Follow-up data
were obtained in 100% of the 288 patients.
The median duration of follow-up was 845 days
(minimum to maximum post-discharge censor dura-
tion: 598 to 1,098 days). Thirty-nine patients (13.5%)experienced MACE. These events included 3 cardiac
deaths, 14 hospitalizations for recurrent MI, and 22
episodes of heart failure (Killip class 3 or 4 heart
failure or deﬁbrillator implantation). Of 39 patients
with MACE, 20 (6.9%) experienced MACE post-
discharge. Myocardial remote zone native T1 was
associated with all MACE (p ¼ 0.008). Remote zone
native T1 was associated with MACE post-discharge
(1-ms increase in native T1: hazard ratio: 1.016; 95%
CI: 1.000 to 1.032; p ¼ 0.048), including after adjust-
ment for LV end-diastolic volume at baseline
(p ¼ 0.051) or the temporal changes in CRP concen-
tration (p ¼ 0.041) and circulating numbers of
monocytes (p ¼ 0.036) and other leukocyte sub-
populations (all p < 0.05) (Online Table 8).
Remote zone native T1 was also associated with all-
cause death or heart failure hospitalization (n ¼ 30
events during admission and post-discharge; 1.014;
95% CI: 1.000 to 1.028; p ¼ 0.049), including after
adjustment for LV end-diastolic volume (p ¼ 0.055)
and change in LV ejection fraction (p ¼ 0.028). In an
exploratory analysis instigated during peer review, a
native T1 cutoff of 969 ms had a negative predictive
value of 0.84 for all cardiovascular outcomes com-
bined (Online Appendix).
The net reclassiﬁcation index and C-index indi-
cated that adding remote zone native T1 did not alter
the predictive value of the models (Online Appendix).
DISCUSSION
We used CMR to measure native T1 in myocardial
regions of interest in a large cohort of STEMI survi-
vors enrolled acutely during usual care, and we
assessed the pathophysiology and prognostic impor-
tance of remote zone tissue.
The main ﬁndings of our study were:
1. The upper tertile of remote zone native T1 values
approximated infarct zone T1 values.
2. Remote myocardial native T1 measured in STEMI
survivors on average 2 days post-MI was indepen-
dently associated with systemic inﬂammation
and the size of MI. The temporal changes in
circulating monocyte cell numbers early post-MI
were independently associated with remote zone
native T1 and subsequent LV remodeling at
6 months, supporting a potential mechanistic
link between inﬂammation and adverse LV
remodeling.
3. Remote myocardial native T1 was associated
with changes in LV end-diastolic volume 6 months
post-MI, independent of the initial severity of MI,
as revealed by microvascular obstruction and
LV end-diastolic volume 2 days post-MI. Remote
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proBNP concentrations at 6 months.
4. Remote myocardial native T1 was independently
associated with post-discharge adverse cardiac
events, including MACE and all-cause death and
heart failure hospitalization during longer-term
follow-up.
5. A native T1 value <969 ms (i.e., below the upper
tertile) had a high negative predictive value for
adverse cardiovascular outcomes.
The potential clinical utility of a cutoff for the
middle versus upper tertile of remote zone T1 for risk
assessment merits further prospective assessment.
Quantitative T1 mapping with CMR has provided
regional measurements of tissue characteristics that
were temporally associated with reperfusion injury
(persistent ST-segment elevation on the ECG), the
size of MI (area at risk and infarct size), inﬂammation,
and LV and clinical outcomes in the longer term.
Native T1 is strongly determined by tissue water
content and cellularity (14,15), and myocardial native
T1 increases with inﬂammatory cell inﬁltration, as
revealed by histopathology in patients who under-
went cardiac transplant with features of acute rejec-
tion (37). An increase in myocardial remote zone
native T1 early post-MI most likely reﬂects edema and
hypercellularity (9–11,37). In fact, the upper tertile of
remote zone native T1 overlapped with native T1
values in the infarct zone (Table 2) and native T1
values in myocardial edema, as reported by Ferreira
et al. (38). An alternative explanation could be that
remote zone ischemia could cause native T1 elevation
through microvascular dilation and increased blood
volume (39); however, there was no relationship be-
tween the number of diseased coronary arteries and
remote zone native T1 (Table 1). Remote zone native
T1 and NT-proBNP levels at baseline were not asso-
ciated, implying that LV wall stress alone is unlikely
to be a determinant of native T1 acutely, which is
in contrast to the striking associations that we
have observed between remote zone native T1
and reperfusion injury and inﬂammation. Reperfu-
sion injury was relatively common in our cohort
(Table 1), perhaps reﬂecting an unselected real-life
STEMI population.
Our clinical ﬁndings are consistent with pre-clinical
observations that monocytes participate in remote
zone inﬂammation and remodeling (5–10) (Online
Appendix). Remote zone native T1 was independently
associated with LV remodeling at 6 months post-
STEMI as revealed by CMR and NT-proBNP levels.
These observations explain why native T1 in remote
myocardium early post-MI might inﬂuence longer-term prognosis because adverse remodeling is
strongly associated with reduced survival post-MI
(2). Acute inﬂammation early post-STEMI may be a
target for therapy (5,13). Future studies should as-
sess whether or not remote zone T1 might be inﬂu-
enced by therapeutic interventions in STEMI patients
and, therefore, potentially may represent a quantita-
tive surrogate biomarker of therapeutic effect in
the heart.
Because a gadolinium contrast agent is not needed
for native T1 CMR, this biomarker may be informative
in a broader range of patients with MI, including
those with severe renal dysfunction for whom
contrast CMR is contraindicated. This hypothesis
merits further prospective assessment in future
studies. Our study does not permit inference on
causality, and other interpretations of our data are
possible. A higher T1 value of remote myocardium
may indicate patients with more diffuse ﬁbrosis,
possibly reﬂecting underlying microvascular disease
and an increased susceptibility to inﬂammation
injury. Although we did not systematically assess for
remote zone ischemia using fractional ﬂow reserve or
stress CMR, we think that the absence of an associa-
tion with multivessel coronary disease counts against
ischemia as the main cause of native T1 elevation in
the myocardial remote zone.
STUDY LIMITATIONS. We do not have information on
wall stress, which could inﬂuence remote zone
pathophysiology. Future research should determine
the natural history and clinical signiﬁcance of native
T1 changes during longer-term follow-up.
CONCLUSIONS
In acute STEMI survivors, remote zone native T1
was temporally linked with reperfusion injury and
inﬂammation and independently associated with LV
remodeling and adverse cardiovascular outcomes.
The upper T1 tertile represents a potential cutoff for
prognostication that merits further study.
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: In acute
STEMI survivors, CMR of remote myocardial tissue
changes, as revealed by measurement of native T1, pro-
vides information that is linked with reperfusion injury
and inﬂammation. Remote zone native T1 is indepen-
dently associated with LV remodeling and adverse car-
diovascular outcomes.
TRANSLATIONAL OUTLOOK: Elevated remote zone
native T1 in the upper tertile may represent an imaging
biomarker for prognostication in survivors of acute
STEMI, including for adverse LV remodeling and all-cause
death and heart failure in the longer term. This possibility
merits further prospective validation to conﬁrm or refute
the potential utility of this imaging biomarker in clinical
practice.
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